Allele loss and point mutation in codons 12 and 61 of the c‐Ha‐ras oncogene in carcinogen‐transformed human breast epithelial cells

Molecular Carcinogenesis

Volumn 9, Issue 1, 1994, Pages 46-56

  Zhang, Pei‐Li ^a   Calaf, Gloria ^a   Russo, Jose ^a  

^a Philadelphia Fox Chase Cancer Centre   (United States)

Author keywords

allele specific oligonucleotide; c Ha ras; human breast epithelial cells; Oncogene; polymerase chain reaction

Indexed keywords

BENZO[A]PYRENE; DIMETHYLBENZ[A]ANTHRACENE; METHYLNITRONITROSOGUANIDINE; METHYLNITROSOUREA;

ARTICLE; BREAST CANCER; CELL TRANSFORMATION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; ONCOGENE H RAS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; ALLELES; ANIMAL; BASE SEQUENCE; BREAST; BREAST NEOPLASMS; CARCINOGENICITY TESTS; CARCINOGENS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CODON; DNA PROBES; DNA, NEOPLASM; EPITHELIUM; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENES, RAS; HUMAN; IMMUNOBLOTTING; MICE; MICE, SCID; MOLECULAR SEQUENCE DATA; NUCLEIC ACID HYBRIDIZATION; PHENOTYPE; POINT MUTATION; POLYMERASE CHAIN REACTION; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028029115     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.2940090109     Document Type: Article

References (77)

1. Direct mutagenesis of Ha‐ras‐1 oncogenes by N‐nitroso‐N‐methylurea during initiation of mammary carcinogenesis in rats
2. Mouse skin carcinoma induced in vivo by chemical carcinogens have a transforming Harvey‐ras oncogene
3. ras genes
4. The ras gene family and human carcinogenesis
5. ras oncogenes in chemical carcinogenesis
6. Evidence of enhancement of the ras oncogene protein product (p21) in a spectrum of human tumors
7. ras gene alterations and enhanced levels of ras p21 expression in a spectrum of benign and malignant human mammary tissues
8. Amplified expression of p21 ras protein in hormone‐dependent mammary carcinomas of humans and rodents
9. Prognostic significance of the expression of a ras protein with a molecular weight of 21,000 by human breast cancer
10. Loss of c‐H‐ras‐1 allele and aggressive human primary breast carcinomas
11. Oncogenes in human cancers and in chemically induced animal tumors
12. Incidence of activating ras oncogene mutations associated with primary and metastatic human breast cancer
13. Induction of mammary carcinomas in rats by nitrosomethylurea involves malignant activation in H‐ras‐1 locus by single point mutations
14. Specific activation of the cellular Harvey‐ras oncogene in dimethylbenzanthracene‐induced mouse mammary tumors
15. Coexpression of MMTV/v‐Ha‐ras and MMTV/c‐myc genes in transgenic mice: Synergistic action of oncogenes in vivo
16. The transformation of primary and established mouse mammary epithelial cells by p21 ras is concentration dependent
17. New acceptor cell for transfected genomic DNA: Oncogene transfer into a mouse mammary epithelial cell line
18. Expression of oncogenes mil and ras abolishes the in vivo differentiation of mammary epithelial cells
19. Transformation of human breast epithelial cells by c‐Ha‐rasoncogene
20. The multistep nature of cancer
21. Critical significance of breast structure in the induction of mammary cancer in the rat
22. Developmental stage of the rat mammary gland as determinant of its susceptibility to 7, 12‐dimethylbenz(a)anthracene
23. Mammary carcinogenesis by 3‐methylcholanthrene: Inhibitory effect of pregnancy and lactation on tumor induction
24. Biological and molecular basis of mammary carcinogenesis
25. Induction of transformation and continuous cell lines from normal human mammary epithelial cells by exposure to benzo(a)pyrene
26. Transformation of human breast epithelial cells by chemical carcinogens
27. In vitro transformation of human epithelial cells
28. Expression of phenotypical changes by human breast epithelial cells treated with carcinogens in vitro
29. Developing concepts on environmental cancer: The role of geographical pathology
30. Formation of mutagens in beef and beef extract during cooking
31. Isolation and characterization of spontaneously immortalized human breast epithelial cell line, MCF‐10F
32. Ultrastructural and immunocytochemical characterization of an immortalized human breast cell line, MCF‐10A
33. Isolation of high‐molecular weight DNA from mammalian cells
34. The human dopamine D2 receptor gene is located on chromosome 11 at q22‐q23 and identifies a Taq1 RFLP
35. Primer‐directed enzymatic amplification of DNA with a thermostable DNA polymerase
36. Activating missense Ha‐ras‐1 gene in a malignant subset of bladder lesions induced by N‐butyl‐N‐(4‐hydroxybutyl) nitrosamine or N‐[4‐(5‐nitro‐2‐furanyl)‐2‐thiazolyl]formamide
37. Base compositionindependent hybridization in tetramethylammonium chloride: A method for oligonucleotide screening of highly complex gene libraries
38. Mutational activation of c‐Ha‐ras gene in squamous cell carcinomas of rat zymbal gland induced by carcinogenesis
39. A human gastric carcinoma contains a single mutated and an amplified normal allele of the Ki‐ras oncogene
40. Relationship between chemically induced Ha‐ras mutation and transformation of BALB/c3T3 cells: Evidence for chemical‐specific activation and cell type‐specific recruitment of oncogene in transformation
41. Supercoil sequencing
42. Using mini‐prep plasmid for sequencing double strand templates with Sequenase
43. DNA sequencing with chain termination inhibitor
44. Loss of genes on the short arm of chromosome 11 in bladder cancer
45. Loss of alleles at loci on human chromosome 11 during genesis of Wilms' tumor
46. Alterations of myc, myb, and Ha‐ras proto‐oncogenes in cancers are frequent and show clinical correlation
47. Proto‐oncogene abnormalities in human breast cancer: Correlations with anatomic features and clinical course of disease
48. High frequency of rare alleles of the human c‐Ha‐ras‐1 protooncogene in breast cancer patients
49. Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue
50. Unique allelic restriction fragments of the human Ha‐ras locus in leukocyte and tumor DNAS of cancer patients
51. Molecular lesions involved in the progression of a human breast cancer
52. Somatic deletions and mutations of c‐Ha‐ras gene in human cervical cancers
53. Human tumor suppressor genes
54. Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells
55. Loss of genes on the short arm of chromosome 11 in bladder cancer
56. Somatic deletions and duplication of genes on chromosomes in Wilms' tumor
57. Loss of heterozygosity in the embryonal tumors suggests a common pathogenetic mechanism
58. Transformation of NIH 3T3 cells by microinjection of Ha‐ras p21 protein
59. Monoclonal antibodies of predefined specificity detect activated ras gene expression in human mammary carcinomas
60. Amplified expression of p21 ras protein in hormone‐dependent mammary carcinomas of humans and rodents
61. Mutations of the Kirsten‐ras proto‐oncogene in human pre‐leukemia
62. Oncogene activation in chemical carcinogenesis
63. A molecular approach to leukemogenesis: Mouse lymphomas contain an activated c‐ras oncogene
64. Unique transforming gene in carcinogentransformed mouse cell
65. Effects of donor age on neoplastic transformation of adult mouse bladder epithelium in vitro
66. Induction of mammary carcinomas in rats by nitroso‐methylurea involves malignant activation of Ha‐ras‐1 locus by single point mutations
67. Prevalence of ras gene mutation in human colorectal cancers
68. Analysis of ras gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes
69. DNA repair, oncogene and carcinogenesis
70. Biological properties of human c‐Ha‐ras 1 genes mutated at codon 12
71. Acquisition of transforming properties by alternative point mutations within c‐bas/has human proto‐oncogene
72. Three different mutations in codon 61 of the human N‐ras gene detected by synthetic oligonucleotide hybridization
73. Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors
74. Biological and biochemical properties of human ras genes mutated at codon 61
75. A transforming ras gene in tumorigenic guinea pig cell lines initiated by diverse chemical carcinogens